Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

David G Mann

Datos Biográficos

ID9596271
NOMBREDavid G Mann
NOMBRESDavid G
APELLIDOMann
FIRMAMANN D G
AFILIACIONESBaylor College of Medicine
ORCID0000-0003-0522-6802
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
OBRAS COMO AUTOR2
OBRAS COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN1997
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0
  • Harm reduction in paediatric off-label therapy

    Alex Gariti, Rebecca Johnson et al.•ARTICLE•Journal of Medical Ethics•2026

    Cystic fibrosis (CF) is a life-limiting genetic disease frequently associated with pancreatic insufficiency (PI), traditionally considered irreversible. CF transmembrane conductance regulator modulators such as elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta) have transformed CF care yet remain FDA-approved only for children aged 2 years and older. We present the case of a 9-month-old female with CF and PI whose mother, highly health-literate and…

  • Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia

    D MANN, David G Mann•ARTICLE•American Journal of Public Health•1997•Referencias: 2

    Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia. D MannCopyRight https://doi.org/10.2105/AJPH.87.4.692 Published Online: October 07, 2011

Sin obras prominentes en esta página.

  • Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia

    D MANN, David G Mann•ARTICLE•American Journal of Public Health•1997•Referencias: 2

    Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia. D MannCopyRight https://doi.org/10.2105/AJPH.87.4.692 Published Online: October 07, 2011

  • Harm reduction in paediatric off-label therapy

    Alex Gariti, Rebecca Johnson et al.•ARTICLE•Journal of Medical Ethics•2026

    Cystic fibrosis (CF) is a life-limiting genetic disease frequently associated with pancreatic insufficiency (PI), traditionally considered irreversible. CF transmembrane conductance regulator modulators such as elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta) have transformed CF care yet remain FDA-approved only for children aged 2 years and older. We present the case of a 9-month-old female with CF and PI whose mother, highly health-literate and…

Adolescent Sexual and Reproductive Health (1 obra) · Best interests (1 obra) · Cystic fibrosis (1 obra) · Cystic Fibrosis Research Advances (1 obra) · Cystic fibrosis transmembrane conductance regulator (1 obra) · Disease (1 obra) · Do no harm (1 obra) · Environmental health (1 obra) · Ethics and Legal Issues in Pediatric Healthcare (1 obra) · Family medicine (1 obra)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae